Dimensional Fund Advisors
GMAB icon

Dimensional Fund Advisors’s Genmab GMAB Stock Holding History

Dimensional Fund Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Sell
49,015
-7,423
-13% -$197K ﹤0.01% 2814
2026
Q1 		$1.51M Buy
56,438
+815
+1% +$24.4K ﹤0.01% 2761
2025
Q4 		$1.71M Sell
55,623
-707
-1% -$22K ﹤0.01% 2764
2025
Q3 		$1.73M Buy
56,330
+3,225
+6% +$78.6K ﹤0.01% 2800
2025
Q2 		$1.1M Buy
53,105
+2,284
+4% +$46.9K ﹤0.01% 2870
2025
Q1 		$995K Buy
50,821
+5,206
+11% +$109K ﹤0.01% 2886
2024
Q4 		$952K Sell
45,615
-24,894
-35% -$547K ﹤0.01% 2925
2024
Q3 		$1.72M Sell
70,509
-14,543
-17% -$389K ﹤0.01% 2813
2024
Q2 		$2.14M Sell
85,052
-8,760
-9% -$248K ﹤0.01% 2748
2024
Q1 		$2.81M Buy
93,812
+256
+0.3% +$7.52K ﹤0.01% 2709
2023
Q4 		$2.98M Sell
93,556
-1,228
-1% -$38.6K ﹤0.01% 2695
2023
Q3 		$3.34M Buy
94,784
+1,023
+1% +$39K ﹤0.01% 2641
2023
Q2 		$3.56M Buy
93,761
+19,617
+26% +$782K ﹤0.01% 2629
2023
Q1 		$2.8M Buy
+74,144
New +$2.85M ﹤0.01% 2652
2022
Q3 		$1.76M Buy
54,862
+1,764
+3% +$61.9K ﹤0.01% 2748
2022
Q2 		$1.73M Buy
53,098
+34,855
+191% +$1.13M ﹤0.01% 2785
2022
Q1 		$660K Buy
18,243
+2,792
+18% +$95.8K ﹤0.01% 3085
2021
Q4 		$611K Buy
15,451
+9,509
+160% +$397K ﹤0.01% 3125
2021
Q3 		$260K Buy
5,942
+660
+12% +$29.6K ﹤0.01% 3305
2021
Q2 		$216K Buy
+5,282
New +$204K ﹤0.01% 3325
2021
Q1 		– Sell
-5,282
Closed -$215K – 3415
2020
Q4 		$215K Buy
+5,282
New +$197K ﹤0.01% 3210

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dimensional Fund Advisors's GMAB Position: Q2 2026 in Review

Dimensional Fund Advisors reduced its Genmab (GMAB) stake by 13% in Q2 2026, selling an estimated $197K and leaving 49,015 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2814.

Dimensional Fund Advisors first reported a position in GMAB in Q4 2020 and has held it in 21 quarters since. The position peaked at $3.56M in Q2 2023. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Dimensional Fund Advisors held 49,015 shares of Genmab worth $1.35M as of Q2 2026.
  • Dimensional Fund Advisors sold 7,423 Genmab shares in Q2 2026, an estimated $197K.
  • Genmab made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2814 holding.
  • Dimensional Fund Advisors first reported a position in Genmab in Q4 2020 and has held it in 21 quarters since.
  • Dimensional Fund Advisors's Genmab position peaked at $3.56M in Q2 2023.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.